AMILI is the #1 precision gut microbiome company in Southeast Asia, based in Singapore. AMILI hosts Southeast Asia’s first and only gut microbiome transplant bank and the world’s largest multi-ethnic Asian gut microbiome database. Our precision-driven, end-to-end platform captures unparalleled insights into gut microbiome abundance, functionality, and its impact on health. For more information, visit www.amili.asia.
| Website | http://www.amili.asia/ |
| Employees | 56 (46 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Gut Microbiome, Precision Medicine, Microbiome Diagnostics, Predictive Algorithms, Data Analytics, Biotechnology, Digital Health, Personalized Medicine, Health Analytics, Diagnostic Tests, Microbiome Analysis, Gut Health, Microbial Ecology, Scientific Research, Clinical Diagnostics, Bioinformatics, Consumer Health, Health Technology, Therapeutic Interventions |
| Competitors | Ancestry, Invitae, MyHeritage, Helix, Color, Gene by Gene, FamilyTreeDNA, Living DNA, 23andMe Inc, Sestina Bio, LLC. +35 more (view full list) |
Looking for a particular AMILI employee's phone or email?
Jeremy Lim is the CEO of AMILI.
46 people are employed at AMILI.